Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 3/2012

01.04.2012

Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study

verfasst von: Frederick A. Spencer, Aimee Kroll, Darleen Lessard, Cathy Emery, Alla V. Glushchenko, Luigi Pacifico, George Reed, Joel M. Gore, Robert J. Goldberg

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

The prevalence of isolated calf deep vein thrombosis (DVT) in the community setting is relatively unexplored. Confusion remains with regards to its management and contemporary natural history. The purpose of this investigation was to describe the number of cases of calf DVT in the community, use of early management strategies, and rates of venous thromboembolism (VTE) recurrence and major bleeding. The medical records of residents of the Worcester (MA) metropolitan area with ICD-9 codes consistent with potential VTE during 4 study years (1999/2001/2003/2005) were validated by trained nurses. Patient demographic/clinical characteristics, treatment practices, and outcomes were evaluated. Isolated calf DVT was diagnosed in 166 (11.1%) of 1,495 patients with lower extremity DVT. Patients with calf DVT were less likely to be discharged on anticoagulants or with an IVC filter than patients with proximal DVT (84.1 vs. 92.3%). The rates of VTE recurrence and pulmonary embolism did not differ significantly between patients with calf DVT and proximal DVT at 6 months (11.0 vs. 8.7%, 2.6 vs. 1.8%, respectively). Patients with calf DVT had higher adjusted risk of early (14-day) VTE recurrence/extension (OR 2.34, 95% CI 1.01–5.44). Patients with calf DVT had lower rates of major bleeding at 6 months compared to patients with proximal DVT (5.2 vs. 9.3%, P = 0.04). Rates of recurrent VTE and major bleeding following calf DVT in the community are much higher than in randomized clinical trials of patients with proximal or calf DVT. Further study of management strategies for isolated calf DVT is needed.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U (1985) Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 2:515–518PubMedCrossRef Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U (1985) Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 2:515–518PubMedCrossRef
2.
Zurück zum Zitat Lohr JM, Kerr TM, Lutter KS, Cranley RD, Spirtoff K, Cranley JJ (1991) Lower extremity calf thrombosis: to treat or not to treat? J Vasc Surg 14:618–623PubMedCrossRef Lohr JM, Kerr TM, Lutter KS, Cranley RD, Spirtoff K, Cranley JJ (1991) Lower extremity calf thrombosis: to treat or not to treat? J Vasc Surg 14:618–623PubMedCrossRef
3.
Zurück zum Zitat Labropoulos N, Kang SS, Mansour MA, Giannoukas AD, Moutzouros V, Baker WH (2002) Early thrombus remodelling of isolated calf deep vein thrombosis. Eur J Vasc Endovasc Surg 23:344–348PubMedCrossRef Labropoulos N, Kang SS, Mansour MA, Giannoukas AD, Moutzouros V, Baker WH (2002) Early thrombus remodelling of isolated calf deep vein thrombosis. Eur J Vasc Endovasc Surg 23:344–348PubMedCrossRef
4.
Zurück zum Zitat Moreno-Cabral R, Kistner RL, Nordyke RA (1976) Importance of calf vein thrombophlebitis. Surgery 80:735–742PubMed Moreno-Cabral R, Kistner RL, Nordyke RA (1976) Importance of calf vein thrombophlebitis. Surgery 80:735–742PubMed
5.
Zurück zum Zitat Partsch H (2001) Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation. Vasa 30:195–204PubMedCrossRef Partsch H (2001) Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation. Vasa 30:195–204PubMedCrossRef
6.
Zurück zum Zitat Cogo A, Lensing AW, Koopman MM et al (1998) Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. BMJ 316:17–20PubMedCrossRef Cogo A, Lensing AW, Koopman MM et al (1998) Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. BMJ 316:17–20PubMedCrossRef
7.
Zurück zum Zitat Birdwell BG, Raskob GE, Whitsett TL et al (1998) The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med 128:1–7PubMed Birdwell BG, Raskob GE, Whitsett TL et al (1998) The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med 128:1–7PubMed
8.
Zurück zum Zitat Spencer FA, Emery C, Joffe SW et al (2009) Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis 28:401–409PubMedCrossRef Spencer FA, Emery C, Joffe SW et al (2009) Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis 28:401–409PubMedCrossRef
9.
Zurück zum Zitat Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585–593PubMedCrossRef Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585–593PubMedCrossRef
10.
Zurück zum Zitat Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692–694PubMedCrossRef Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692–694PubMedCrossRef
11.
Zurück zum Zitat Palareti G, Cosmi B, Lessiani G et al (2010) Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study. Thromb Haemost 104:1063–1070PubMedCrossRef Palareti G, Cosmi B, Lessiani G et al (2010) Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study. Thromb Haemost 104:1063–1070PubMedCrossRef
12.
Zurück zum Zitat Lohr JM, Fellner AN (2010) Isolated calf vein thrombosis should be treated with anticoagulation. Dis Mon 56:590–600PubMedCrossRef Lohr JM, Fellner AN (2010) Isolated calf vein thrombosis should be treated with anticoagulation. Dis Mon 56:590–600PubMedCrossRef
13.
Zurück zum Zitat Masuda EM, Kistner RL (2010) The case for managing calf vein thrombi with duplex surveillance and selective anticoagulation. Dis Mon 56:601–613PubMedCrossRef Masuda EM, Kistner RL (2010) The case for managing calf vein thrombi with duplex surveillance and selective anticoagulation. Dis Mon 56:601–613PubMedCrossRef
14.
Zurück zum Zitat Bernardi E, Camporese G, Buller HR et al (2008) Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial. Jama 300:1653–1659PubMedCrossRef Bernardi E, Camporese G, Buller HR et al (2008) Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial. Jama 300:1653–1659PubMedCrossRef
15.
Zurück zum Zitat Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ (2008) Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:454S–545SPubMedCrossRef Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ (2008) Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:454S–545SPubMedCrossRef
16.
Zurück zum Zitat Decousus H, Leizorovicz A, Parent F et al (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 338:409–415PubMedCrossRef Decousus H, Leizorovicz A, Parent F et al (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 338:409–415PubMedCrossRef
17.
Zurück zum Zitat Fiessinger JN, Huisman MV, Davidson BL et al (2005) Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. JAMA 293:681–689PubMedCrossRef Fiessinger JN, Huisman MV, Davidson BL et al (2005) Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. JAMA 293:681–689PubMedCrossRef
18.
Zurück zum Zitat Buller HR, Davidson BL, Decousus H et al (2004) Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 140:867–873PubMed Buller HR, Davidson BL, Decousus H et al (2004) Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 140:867–873PubMed
19.
Zurück zum Zitat Pinede L, Ninet J, Duhaut P et al (2001) Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 103:2453–2460PubMed Pinede L, Ninet J, Duhaut P et al (2001) Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 103:2453–2460PubMed
20.
Zurück zum Zitat Schulman S, Rhedin AS, Lindmarker P et al (1995) A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 332:1661–1665PubMedCrossRef Schulman S, Rhedin AS, Lindmarker P et al (1995) A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 332:1661–1665PubMedCrossRef
21.
Zurück zum Zitat Hansson PO, Sorbo J, Eriksson H (2000) Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 160:769–774PubMedCrossRef Hansson PO, Sorbo J, Eriksson H (2000) Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 160:769–774PubMedCrossRef
22.
Zurück zum Zitat Heit JA, Mohr DN, Silverstein MD, Petterson TM, O’Fallon WM, Melton LJ 3rd (2000) Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 160:761–768PubMedCrossRef Heit JA, Mohr DN, Silverstein MD, Petterson TM, O’Fallon WM, Melton LJ 3rd (2000) Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 160:761–768PubMedCrossRef
Metadaten
Titel
Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study
verfasst von
Frederick A. Spencer
Aimee Kroll
Darleen Lessard
Cathy Emery
Alla V. Glushchenko
Luigi Pacifico
George Reed
Joel M. Gore
Robert J. Goldberg
Publikationsdatum
01.04.2012
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 3/2012
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-011-0670-x

Weitere Artikel der Ausgabe 3/2012

Journal of Thrombosis and Thrombolysis 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.